Image For Activity Cover
GRNS20EM2140 - CME/CMLE - Advances in Targeted Therapies for Advanced NSCLC
Course Description

Advances in Targeted Therapies for Advanced NSCLC ​

This enduring material from our fourth videoconference on advanced NSCLC for pathologists and laboratory professionals will consist of a 20-minute didactic presentation by a subject matter expert on advances in targeted therapies for patients with advanced NSCLC. In the remaining 40 minutes, two participants will present and share real-world cases and challenges from their institutions and seek feedback from participants and subject matter experts. The session will provide knowledge and best practices related to targeted therapies in advanced NSCLC and guidance on real-life challenges they may face in their institutions. 

The videoconferences in this series utilize the Project ECHO® approach, leveraging technology to provide access to scarce resources, help participants master complex topics through case-based learning, facilitate peer-to-peer sharing of best practices to improve knowledge and outcomes, reduce peer isolation, and foster professional development. 

This is an online course.  If you attended the live event please claim credit Here 

The activity offers 1.0 CME/CMLE credit. 

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. 

Faculty/Authors

Christian Kunder, MD
Stanford Hospital and Clinics
Surgical Pathology
Stanford, CA 

VOLUNTEER CONTRIBUTORS:

M Zehra Z Ordulu Sahin, MD
University of Florida, College of Medicine
Department Pathology, Immunology, and Laboratory Medicine
Gainesville, FL 

Fei Dong, MD
Associate Program Director, Anatomic Pathology
Brigham and Women’s Hospital
Boston, MA 

Physician's Competency: Patient care, Medical knowledge, Interpersonal and Communication Skills, Professionalism   

CME/CMLE Credit: 1.0
Estimated Completion Time: 1.0 hour
Format: Online educational activity

Credit Designation Statement

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

ASCP designates this enduring material for a maximum of 1.0 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel. 

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time 

 
Method of Participation

To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line. 

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc. 

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Review the Educational Activity.
  5. Submit the Post-Activity Survey.
  6. Submit the course Evaluation.
  7. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 10/15/2021       
Review Date:
Expiration Date: 10/15/2024      




Course Objectives

Upon completion of this activity, you will be able to:

  • Discuss current and emerging treatment options for advanced NSCLC and their mechanisms of action; 

  • Guide medical oncologists and other members of the interdisciplinary cancer care team on the diagnosis, testing, and management of patients with advanced NSCLC.  

Summary
Availability: On-Demand
Credit Offered:
1 CME/CMLE Credit
Contains: 4 Courses
Powered By